Etiracetam: Difference between revisions

Revision as of 15:05, 11 February 2016 editEdgar181 (talk \| contribs)Extended confirmed users196,325 edits removed Category:Pyrrolidones using HotCat ← Previous edit		Revision as of 17:38, 25 February 2016 edit undoDePiep (talk \| contribs)Extended confirmed users294,285 editsm remove setting of the default value (\|drug_name=pagename) (via AWB script)Next edit →
Line 7:		Line 7:
	\| image2 = Etiracetam3d.png		\| image2 = Etiracetam3d.png
	\| caption = 1 : 1 mixture (racemate)		\| caption = 1 : 1 mixture (racemate)
	\| drug_name = Etiracetam
	<!-- Clinical data -->		<!-- Clinical data -->
	\| tradename =		\| tradename =

Revision as of 17:38, 25 February 2016

This article does not cite any sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed.
Find sources: "Etiracetam" – news · newspapers · books · scholar · JSTOR (December 2009) (Learn how and when to remove this message)

Pharmaceutical compound

Etiracetam
Clinical data

1 : 1 mixture (racemate)
Routes of administration	Oral
ATC code	none
Legal status
Legal status	Unscheduled (US)
Identifiers
IUPAC name (RS)-2-(2-oxopyrrolidin-1-yl)butanamide
CAS Number	33996-58-6
PubChem CID	59708
ChemSpider	53863
UNII	230447L0GL
ChEMBL	ChEMBL1400561
CompTox Dashboard (EPA)	DTXSID5046510
ECHA InfoCard	100.111.445
Chemical and physical data
Formula	C₈H₁₄N₂O₂
Molar mass	170.209 g/mol g·mol
3D model (JSmol)	Interactive image
SMILES CCC(C(=O)N)N1CCCC1=O
InChI InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12) Key:HPHUVLMMVZITSG-UHFFFAOYSA-N
(verify)

Etiracetam is a nootropic drug of the racetam family. It is racemic; its biologically active enantiomeric form is levetiracetam.